BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22513795)

  • 21. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.
    Costea I; Moghrabi A; Laverdiere C; Graziani A; Krajinovic M
    Haematologica; 2006 Aug; 91(8):1113-6. PubMed ID: 16870553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
    Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
    Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals.
    Ozarda Y; Sucu DK; Hizli B; Aslan D
    Cell Biochem Funct; 2009 Dec; 27(8):568-77. PubMed ID: 19764044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
    Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
    Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia.
    Salazar J; Altés A; del Río E; Estella J; Rives S; Tasso M; Navajas A; Molina J; Villa M; Vivanco JL; Torrent M; Baiget M; Badell I
    Pharmacogenomics J; 2012 Oct; 12(5):379-85. PubMed ID: 21747412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
    Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children.
    Damnjanovic T; Milicevic R; Novkovic T; Jovicic O; Bunjevacki V; Jekic B; Lukovic L; Novakovic I; Redzic D; Milasin J
    J Pediatr Hematol Oncol; 2010 May; 32(4):e148-50. PubMed ID: 20445408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
    Yang L; Hu X; Xu L
    Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
    El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN
    Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico.
    Ruiz-Argüelles GJ; Coconi-Linares LN; Garcés-Eisele J; Reyes-Núñez V
    Hematology; 2007 Oct; 12(5):387-91. PubMed ID: 17891601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
    Nasr AS; Sami RM; Ibrahim NY
    J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia.
    Nagele P; Zeugswetter B; Wiener C; Burger H; Hüpfl M; Mittlböck M; Födinger M
    Anesthesiology; 2008 Jul; 109(1):36-43. PubMed ID: 18580170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate.
    Choi YJ; Park H; Lee JS; Lee JY; Kim S; Kim TW; Park JS; Kim JE; Yoon DH; Suh C
    Hematol Oncol; 2017 Dec; 35(4):504-509. PubMed ID: 27781293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
    Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
    Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.
    Yazıcıoğlu B; Kaya Z; Güntekin Ergun S; Perçin F; Koçak Ü; Yenicesu İ; Gürsel T
    Turk J Haematol; 2017 Jun; 34(2):143-150. PubMed ID: 27094381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mexican Childhood Acute Lymphoblastic Leukemia: A Pilot Study of the MDR1 and MTHFR Gene Polymorphisms and Their Associations with Clinical Outcomes.
    Ramírez-Pacheco A; Moreno-Guerrero S; Alamillo I; Medina-Sanson A; Lopez B; Moreno-Galván M
    Genet Test Mol Biomarkers; 2016 Oct; 20(10):597-602. PubMed ID: 27533339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of methylenetetrahydrofolate reductase gene (MTHFR) 677C>T polymorphism in pediatric cerebrovascular disorders.
    Alsayouf H; Zamel KM; Heyer GL; Khuhro AL; Kahwash SB; de los Reyes EC
    J Child Neurol; 2011 Mar; 26(3):318-21. PubMed ID: 21270470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
    Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
    Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.